EP2217578
[1,2,4]Tríasóló[1,5-a]pýridín- og [1,2,4]tríasóló[1,5-c]pýrimídínefnasambönd og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.10.2008EP published:
4.12.2013EP application number:
08806565.1
EP translation filed:
10.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
9.10.2028Expiry date:
9.10.2022
Title:
[1,2,4]TRIAZOLO[1,5-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE COMPOUNDS AND THEIR USE
Timeline
Today
10.10.2008EP application
4.12.2013EP Publication
10.2.2014Translation submitted
15.3.2014Registration published
9.10.2022Expires
Owner
Name:
Cancer Research Technology LimitedAddress:
Angel Building, 407 St John Street, London EC1V 4AD, GB
Inventor
Name:
PAVÉ, Grégoire, AlexandreAddress:
London, Greater London WC2A 3NL, GB
Name:
FIRTH, James, DonaldAddress:
London, Greater London WC2A 3NL, GB
Name:
STEWART, LornaAddress:
London, Greater London WC2A 3NL, GB
Name:
RIGOREAU, Laurent, Jean, MartinAddress:
London, Greater London WC2A 3NL, GB
Name:
WYNNE, Emma, LouiseAddress:
London, Greater London WC2A 3NL, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
978792 PDate:
10.10.2007Country:
US
Number:
0719803Date:
10.10.2007Country:
GB
Classification
Categories:
C07D 249/18, C07D 401/04, C07D 403/04, C07D 403/14, C07D 405/04, C07D 407/14, C07D 409/04, C07D 413/04, C07D 413/14, C07D 471/04
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.8.2014
Expires: 9.10.2015
Payer: Árnason Faktor
Number: 8
Paid: 17.8.2015
Expires: 9.10.2016
Payer: Árnason Faktor
Number: 9
Paid: 4.8.2016
Expires: 9.10.2017
Payer: Árnason Faktor
Number: 10
Paid: 13.9.2017
Expires: 9.10.2018
Payer: Árnason Faktor
Number: 11
Paid: 2.8.2018
Expires: 9.10.2019
Payer: Árnason Faktor
Number: 12
Paid: 19.8.2019
Expires: 9.10.2020
Payer: Árnason Faktor
Number: 13
Paid: 28.8.2020
Expires: 9.10.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 29.10.2021
Expires: 9.10.2022
Payer: